DOCK2 and colorectal carcinoma: Additionally, pathway enrichment analysis linked key DMGs to CRC-related signaling pathways, while FM-AFT regression identified novel prognostic genes such as CDH11, EPB41L3, and DOCK2, highlighting the clinical relevance of our findings.